RxDoctor Payments Data

Daniel Modaff, MD

Clinical Cardiac Electrophysiology · Madison, WINPI 1295092104

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Abbott at 49.3% of the total. Reporting peaked in 2021 at $6,360 and has fallen 88.0% since, to $762 in 2025.

$18,948in general payments, 2019–2025

Across 77 payments — averaging $246.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$9K
  • Medtronic$6K
  • Medical Device Business Services, Inc.$2K
  • Boston Scientific$1K
  • Biosense Webster, Inc.$185
  • Atricure, Inc.$131

What the payments were for

  • Consulting fees$4,90026%
  • Speaking & faculty fees$4,00021%
  • Travel & lodging$6,79036%
  • Food & beverage$3,06316%
  • Education$1951%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott35$9,341
Medtronic(2 entities)22$6,281
Medical Device Business Services, Inc.10$1,796
Boston Scientific4$1,215
Biosense Webster, Inc.5$185
Atricure, Inc.1$131

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,948 in reported general payments places this provider in the 60th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

See all clinical cardiac electrophysiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$165,833
Medicare patients
1,167
Services billed
2,764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban106$99,461
XareltoRivaroxaban64$48,944
Flecainide Acetate69$4,714
Metoprolol Succinate188$2,893
Dofetilide27$2,198
Amiodarone Hcl136$1,989
Mexiletine Hcl39$1,981
SotalolSotalol Hcl28$508
Carvedilol44$416
Metoprolol Tartrate45$341
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$310
Digoxin12$188

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →